Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
February 11 2020
February 11th, 2020: we are pleased to announce the publication of our article « A fully implantable...
January 29 2020
Madrid, February 19-22th 2020: Defymed is happy to announce that we won the “Startup Grant for the T...